INFEX Therapeutics Revenue and Competitors

Alderley Edge, UK

Location

$9M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • INFEX Therapeutics's estimated annual revenue is currently $4.3M per year.(i)
  • INFEX Therapeutics's estimated revenue per employee is $155,000
  • INFEX Therapeutics's total funding is $9M.

Employee Data

  • INFEX Therapeutics has 28 Employees.(i)
  • INFEX Therapeutics grew their employee count by 4% last year.

INFEX Therapeutics's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
Chief Clinical Officer & Chair Clinical Development CommitteeReveal Email/Phone
3
Principal ScientistReveal Email/Phone
4
Senior Medicinal ChemistReveal Email/Phone
5
Research LeaderReveal Email/Phone
6
Senior Medicinal ChemistReveal Email/Phone
7
Senior Scientist, BiologyReveal Email/Phone
8
Principal ScientistReveal Email/Phone
9
Senior Research ScientistReveal Email/Phone
10
Research LeaderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35-12%N/AN/A
#2
$16.3M1054%N/AN/A
#3
$107.2M49425%$292MN/A
#4
$2.6M83030%$631.7MN/A
#5
$18.1M117-8%$81MN/A
#6
$1.2M27112%$440MN/A
#7
$54.6M2820%$132.9MN/A
#8
$9.3M60-37%N/AN/A
#9
$21.2M13712%N/AN/A
#10
$408.2M164611%£994.6MN/A
Add Company

What Is INFEX Therapeutics?

We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections.

keywords:N/A

$9M

Total Funding

28

Number of Employees

$4.3M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.4M3559%N/A
#2
$6.7M51N/AN/A
#3
$11.8M5218%N/A
#4
$10.9M54-19%N/A
#5
$6.9M7542%N/A